Improvement of Endothelial Function with Metformin and Rosiglitazone Treatment in Women with Polycystic Ovary Syndrome

    July 2008 in “ European journal of endocrinology ”
    Mojca Jensterle, Miran Šebeštjen, Andrej Janez … Marija Pfeifer
    Studysummary This study found that a 6-month treatment with either metformin or rosiglitazone significantly improved endothelial function in young women with PCOS without any one drug being superior.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on eje.bioscientifica.com →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Long-Term Morbidity of Polycystic Ovary Syndrome Endocrine updates · 2007